About CTMX Dividend Returns
CytomX Therapeutics, Inc. (CTMX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of CTMX over the past year?
CytomX Therapeutics, Inc. (CTMX) delivered a return of 692.97% over the past year. Since CTMX does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in CTMX be worth today?
A $10,000 investment in CytomX Therapeutics, Inc. one year ago would be worth $79,297 today, representing a gain of $69,297.
Q3Does CTMX pay dividends?
CytomX Therapeutics, Inc. (CTMX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CTMX, the total return equals the price-only return.
Q4Did CTMX beat the S&P 500?
Yes, CytomX Therapeutics, Inc. (CTMX) outperformed the S&P 500 by 677.52 percentage points over the past year. CTMX delivered a total return of 692.97%, compared to the S&P 500's 15.45%. This 677.52pp alpha means investors in CTMX earned more than a passive S&P 500 index fund.
Q5What is CTMX's worst drawdown?
CytomX Therapeutics, Inc. (CTMX) experienced a maximum drawdown of -41.14% over the past year, declining from its peak on 2025-06-12 to its trough on 2025-08-14. The stock recovered to its prior peak by 2025-09-29. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is CTMX's long-term total return over 10, 20, or 30 years?
CytomX Therapeutics, Inc. (CTMX) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -58.4% (-8.4% CAGR) — $10,000 would have grown to $4,163. Over 20 years: -58.4% total return (-4.3% CAGR) — $10,000 → $4,163. Over 30 years: -58.4% total return (-2.9% CAGR) — $10,000 → $4,163. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was CTMX's best and worst year?
CytomX Therapeutics, Inc.'s best calendar year was 2025 with a total return of 301.9%. Its worst year was 2022 with a total return of -64.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 366.3 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).